Halesha Basavarajappa
Affiliations: | Indiana University School of Medicine, Indianapolis, IN, United States |
Google:
"Halesha Basavarajappa"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schwikkard S, Whitmore H, Sishtla K, et al. (2019) The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae ( sensu APGII). Journal of Natural Products |
| Basavarajappa HD, Sulaiman RS, Qi X, et al. (2017) Ferrochelatase is a therapeutic target for ocular neovascularization. Embo Molecular Medicine |
| Lee B, Sun W, Lee H, et al. (2016) Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids. Bioorganic & Medicinal Chemistry Letters |
| Basavarajappa HD, Lee B, Lee H, et al. (2015) Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization. Journal of Medicinal Chemistry. 58: 5015-27 |
| Humnabadkar V, Madhavapeddi P, Basavarajappa H, et al. (2015) Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPase. Journal of Biomolecular Screening. 20: 265-74 |
| Sulaiman RS, Basavarajappa HD, Corson TW. (2014) Natural product inhibitors of ocular angiogenesis. Experimental Eye Research. 129: 161-71 |
| Lee B, Basavarajappa HD, Sulaiman RS, et al. (2014) The first synthesis of the antiangiogenic homoisoflavanone, cremastranone. Organic & Biomolecular Chemistry. 12: 7673-7 |
| Basavarajappa HD, Lee B, Fei X, et al. (2014) Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth. Plos One. 9: e95694 |
| Thériault BL, Basavarajappa HD, Lim H, et al. (2014) Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer. Plos One. 9: e91540 |
| Kale RR, Kale MG, Waterson D, et al. (2014) Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy. Bioorganic & Medicinal Chemistry Letters. 24: 870-9 |